OLMA - Balance Sheet - Olema Pharmaceuticals, Inc.

Current Liabilities	41.8 M
Accounts Payable	4.46 M
Short-Term Debt	1.17 M
Other Current Liabilities	36.1 M
Non-Current Liabilities	257 K
Long-Term Debt	0
Other Non-Current Liabilities	257 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	139.5	68.5	23.7	287.2	338.5	68 K	3.1
Short Term Investments	294.6	193.3	180.7	273.4	0	0	0
Receivables	2.1	0.7	0.3	0	0	0	0
Inventory	0	0	(0.3)	(0.4)	0	0	0
Other Current Assets	2.3	4.0	4.2	3.3	3.6	35 K	93 K
Total Current Assets	438.5	266.5	208.9	287.2	342.1	0.1	3.2
PP&E	1.3	3.3	4.0	4.7	75 K	26 K	26 K
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0
Other Long Term Assets	11.2	7.2	2.8	4.0	0.5	3 K	3 K
Other Assets	0	0	0	0	0	0	0
Total Assets	451.0	276.9	215.6	295.9	342.7	0.1	3.3
LIABILITIES
Accounts Payable	4.5	2.7	0.4	23 K	0.7	0.9	0.1
Short Term Debt	1.2	1.0	1.0	1.9	0	0	0
Other Current Liabilities	36.1	17.9	15.1	7.0	3.2	0.4	85 K
Total Current Liabilities	41.8	21.6	16.5	9.0	4.6	1.4	0.2
Long Term Debt	0	1.4	1.6	2.4	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	9.3
Total Liabilities	42.0	23.1	18.1	11.4	4.6	10.7	9.5
EQUITY
Common Stock	6 K	4 K	3 K	3 K	3 K	1 K	1 K
Retained Earnings	(435.1)	(305.6)	(209.0)	(104.2)	(33.1)	(10.8)	(6.4)
Other Accumulative Comprehensive Income/Loss	0.1	0.3	(1.8)	(0.1)	(342.7)	(9.3)	71 K
Total Equity	409.0	253.9	197.5	284.6	338.1	(10.6)	(6.3)
Total Liabilities and Equity	451.0	276.9	215.6	295.9	342.7	0.1	3.3
SHARES OUTSTANDING
Common Shares Outstanding	58.7	45.2	40.0	39.5	39.3	40.2	14.1

Free